Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an ω3 site ligand
- 1 August 1993
- journal article
- Published by Elsevier in Brain Research
- Vol. 618 (2) , 227-237
- https://doi.org/10.1016/0006-8993(93)91270-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanismsPublished by Elsevier ,2005
- MK-801 SELECTIVELY PROTECTS MOUSE ARCUATE NEURONS IN VIVO AGAINST GLUTAMATE TOXICITYNeuroReport, 1992
- Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult ratsNeuroscience Letters, 1991
- The pharmacotherapy of focal cortical ischaemia in the mouseBrain Research, 1990
- The quantification of brain lesions with anω3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegenerationBrain Research, 1990
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990
- Blockade of excitatory synaptic transmission by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in the hippocampus in vitroNeuroscience Letters, 1988
- Changes in Extracellular Amino Acids During Soman‐and Kainic Acid‐Induced SeizuresJournal of Neurochemistry, 1987
- Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic LocalizationJournal of Neurochemistry, 1983
- Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brainPsychopharmacology, 1982